Akari's robust PK/PD model simulated 10,000 virtual patients informing U.S. FDA MIDD interactions that helped confirm PK/PD model suitability & doses …
Stories
Thrombotic Microangiopathy
Thrombotic microangiopathy following a stem cell transplant is a rare but serious complication that often leads to progressive organ damage and death. Akari is …
Q&A with Miles Nunn, Chief Scientific Officer
1. Can you give us an outline of your role at Akari? Scientific input and oversight to all areas of Akari’s work including strategic direction, regulatory …
[Read more...] about Q&A with Miles Nunn, Chief Scientific Officer
